Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19)

Overview

Journal Semin Thromb Hemost

Publisher Thieme

Specialties Cardiology & Vascular Diseases
Hematology

Date 2020 Sep 4

PMID 32882718

Citations 18

Authors

Brandon Michael Henry

Stefanie W Benoit

Jonathan Hoehn

Giuseppe Lippi

Emmanuel J Favaloro

Justin L Benoit

Affiliations

Soon will be listed here.

Citing Articles

Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.

Suarez-Castillejo C, Calvo N, Preda L, Cordova Diaz R, Toledo-Pons N, Martinez J Int J Mol Sci. 2024; 25(13).

PMID: 39000378 PMC: 11242326. DOI: 10.3390/ijms25137270.

Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease.

Brito-Robinson T, Ayinuola Y, Ploplis V, Castellino F Front Cardiovasc Med. 2024; 11:1406953.

PMID: 38984351 PMC: 11231438. DOI: 10.3389/fcvm.2024.1406953.

Dysregulated Coagulation and Fibrinolysis Are Present in Patients Admitted to the Emergency Department with Acute Hypoxemic Respiratory Failure: A Prospective Study.

Keskinidou C, Vassiliou A, Papoutsi E, Jahaj E, Dimopoulou I, Siempos I Biomedicines. 2024; 12(5).

PMID: 38791043 PMC: 11118913. DOI: 10.3390/biomedicines12051081.

Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity.

Okazaki E, Barion B, da Rocha T, Di Giacomo G, Ho Y, Rothschild C J Thromb Thrombolysis. 2024; 57(4):721-729.

PMID: 38523179 DOI: 10.1007/s11239-024-02961-8.

COVID-19: Not a thrombotic disease but a thromboinflammatory disease.

He S, Blomback M, Wallen H Ups J Med Sci. 2024; 129.

PMID: 38327640 PMC: 10845889. DOI: 10.48101/ujms.v129.9863.

References

Bikdeli B, Madhavan M, Gupta A, Jimenez D, Burton J, Nigoghossian C . Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020; 120(7):1004-1024. PMC: 7516364. DOI: 10.1055/s-0040-1713152. View

Lippi G, Favaloro E . D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020; 120(5):876-878. PMC: 7295300. DOI: 10.1055/s-0040-1709650. View

Idell S, James K, Levin E, Schwartz B, Manchanda N, Maunder R . Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest. 1989; 84(2):695-705. PMC: 548934. DOI: 10.1172/JCI114217. View

Henry B, Lippi G . Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52(6):1193-1194. PMC: 7103107. DOI: 10.1007/s11255-020-02451-9. View

Lippi G, Henry B . Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020; 167:105941. PMC: 7154502. DOI: 10.1016/j.rmed.2020.105941. View

Wang J, Hajizadeh N, Moore E, McIntyre R, Moore P, Veress L . Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020; 18(7):1752-1755. PMC: 7262152. DOI: 10.1111/jth.14828. View

Henry B, de Oliveira M, Benoit S, Plebani M, Lippi G . Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020; 58(7):1021-1028. DOI: 10.1515/cclm-2020-0369. View

Sodhi C, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton W, Wang S . Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol. 2017; 314(1):L17-L31. PMC: 5866432. DOI: 10.1152/ajplung.00498.2016. View

Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P . Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000; 161(2 Pt 1):454-62. DOI: 10.1164/ajrccm.161.2.9712038. View

10.

Lippi G, Wong J, Henry B . Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020; 130(4):304-309. DOI: 10.20452/pamw.15272. View

11.

Brown N, Gainer J, Murphey L, Vaughan D . Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation. 2000; 102(18):2190-6. DOI: 10.1161/01.cir.102.18.2190. View

12.

Lippi G, Sanchis-Gomar F, Henry B . Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med. 2020; 8(7):497. PMC: 7210187. DOI: 10.21037/atm.2020.03.157. View

13.

Henry B, Vikse J, Benoit S, Favaloro E, Lippi G . Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020; 507:167-173. PMC: 7195008. DOI: 10.1016/j.cca.2020.04.027. View

14.

Miles L, Parmer R . Plasminogen receptors: the first quarter century. Semin Thromb Hemost. 2013; 39(4):329-37. PMC: 3938387. DOI: 10.1055/s-0033-1334483. View

15.

Collen D . Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy. J Cell Biochem. 1987; 33(2):77-86. DOI: 10.1002/jcb.240330202. View

16.

Phipps M, Barraza L, LaSota E, Sobieszczyk M, Pereira M, Zheng E . Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort. Hepatology. 2020; 72(3):807-817. PMC: 7300739. DOI: 10.1002/hep.31404. View

17.

Ji H, Zhao R, Matalon S, Matthay M . Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiol Rev. 2020; 100(3):1065-1075. PMC: 7191627. DOI: 10.1152/physrev.00013.2020. View

18.

Aisina R, Mukhametova L . [Structure and functions of plasminogen/plasmin system]. Bioorg Khim. 2015; 40(6):642-57. DOI: 10.1134/s1068162014060028. View

19.

Lippi G, Sanchis-Gomar F, Henry B . COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. Ann Transl Med. 2020; 8(11):693. PMC: 7327324. DOI: 10.21037/atm-20-3989. View

20.

Aggarwal G, Cheruiyot I, Aggarwal S, Wong J, Lippi G, Lavie C . Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020; 45(8):100617. PMC: 7187816. DOI: 10.1016/j.cpcardiol.2020.100617. View